Suraj Kalia
Stock Analyst at Oppenheimer
(2.09)
# 1,265
Out of 4,667 analysts
81
Total ratings
37.74%
Success rate
-3.71%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintains: Outperform | $30 → $32 | $27.17 | +17.78% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $103.44 | -10.09% | 2 | Nov 1, 2024 | |
| ATRC AtriCure | Maintains: Outperform | $32 → $36 | $36.03 | -0.08% | 6 | Oct 30, 2024 | |
| TMDX TransMedics Group | Maintains: Outperform | $200 → $125 | $77.20 | +61.92% | 8 | Oct 29, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $115.93 | +12.14% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $4.07 | +145.70% | 1 | Sep 16, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 | $69.54 | +29.42% | 5 | Sep 12, 2024 | |
| NYXH Nyxoah | Maintains: Outperform | $15 → $13 | $8.21 | +58.34% | 4 | Aug 7, 2024 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $165 → $145 | $73.74 | +96.64% | 4 | Aug 2, 2024 | |
| ITGR Integer Holdings | Initiates: Outperform | $135 | $133.37 | +1.22% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $241.55 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $4.23 | - | 8 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $30 | $15.42 | +94.55% | 5 | Nov 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $15.56 | +92.80% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $10 | $0.49 | +1,934.17% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $84.90 | +14.25% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $25.01 | +11.96% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $3.32 | +35.54% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $4.41 | +262.81% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $541.82 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $60 | $0.30 | +19,701.98% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $184.77 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $5.89 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $32.63 | +206.47% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $75.24 | - | 5 | Sep 12, 2018 |
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $27.17
Upside: +17.78%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $103.44
Upside: -10.09%
AtriCure
Oct 30, 2024
Maintains: Outperform
Price Target: $32 → $36
Current: $36.03
Upside: -0.08%
TransMedics Group
Oct 29, 2024
Maintains: Outperform
Price Target: $200 → $125
Current: $77.20
Upside: +61.92%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $115.93
Upside: +12.14%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $4.07
Upside: +145.70%
Edwards Lifesciences
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $69.54
Upside: +29.42%
Nyxoah
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $8.21
Upside: +58.34%
iRhythm Technologies
Aug 2, 2024
Maintains: Outperform
Price Target: $165 → $145
Current: $73.74
Upside: +96.64%
Integer Holdings
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $133.37
Upside: +1.22%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $241.55
Upside: -
Feb 22, 2024
Downgrades: Perform
Price Target: n/a
Current: $4.23
Upside: -
Nov 15, 2023
Maintains: Outperform
Price Target: $42 → $30
Current: $15.42
Upside: +94.55%
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $15.56
Upside: +92.80%
Jun 23, 2023
Maintains: Outperform
Price Target: $16 → $10
Current: $0.49
Upside: +1,934.17%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $84.90
Upside: +14.25%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $25.01
Upside: +11.96%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $3.32
Upside: +35.54%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $4.41
Upside: +262.81%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $541.82
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $60
Current: $0.30
Upside: +19,701.98%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $184.77
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $5.89
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $32.63
Upside: +206.47%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $75.24
Upside: -